Delivery Order SPE2DB20D3104-SPE2DB25FV9D7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,117.29 to AmerisourceBergen Drug Corp for the supply of Meloxicam 15 mg tablets in unit dose packaging (100s). This competitively awarded, firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, which serves as the company's corporate headquarters and a critical distribution hub...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Meloxicam 15 mg tablets in a 90-count package, with a contract value of $2,000.95 and completion targeted for July 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a child order under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Meloxicam 15 mg tablets in unit dose packaging (100 count) with a contract value of $7,948.48. The order, designated as a firm fixed price delivery order with an ultimate completion date of August 13, 2025, was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,420.47 to AmerisourceBergen Drug Corp for 90 tablets of Meloxicam 15 mg, with a completion date of February 28, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a continuation of the vendor's critical role in federal pharmaceutical procurement. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- This is a $1,223.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Meloxicam 15 mg tablet units, a medication commonly used to treat pain and inflammation. The contract has a period of performance through June 4, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 15 mg meloxicam tablets. The order, valued at $7,916.30, is part of an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a maximum value of $999,999,999 through December 2025. The contract is for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and...
- The Defense Logistics Agency awarded a $61,540 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 tablets of 15 mg meloxicam. The delivery order was issued under an indefinite-delivery/indefinite-quantity multiple award contract vehicle and calls for the pharmaceutical products to be shipped to a facility in Conshohocken, Pennsylvania by July 17, 2023 to support the Agency's medical supply needs. No set aside provisions or subcontractors were identified. The...
- This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 15 mg meloxicam tablets. The contract has a ceiling value of $6,877.13 and a completion date of June 25, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
- This federal contract award, valued at $1,853.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Meloxicam 7.5 mg tablets in 90-count packages. This appears to be a firm-fixed-price delivery order contract, with an ultimate completion date of April 3, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,269.10, is for the delivery of 180 tablets of the medication Meloxicam 15 mg. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of June 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FV9D7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,540.64 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Meloxicam 15 mg. This non-competitive, firm fixed-price delivery order, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a pharmaceutical supply requirement fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The contract is a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant prime vendor position within the Defense Logistics Agency's Medical Supply Chain. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including medications, vaccines, syringes, vials, and specialized medical commodities. This delivery order for Meloxicam, a nonsteroidal anti-inflammatory pain management pharmaceutical, exemplifies the routine pharmaceutical procurement executed under this expansive contract vehicle to support Defense Health Agency and other federal healthcare system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 7/29/25 |